Bob
Senior Member
- Messages
- 16,455
- Location
- England (south coast)
In 'Nature' regarding the delayed CDC paper:
And regarding the NIH/FDA paper:
http://www.nature.com/news/2010/100702/full/news.2010.332.html?s=news_rss
http://www.forums.aboutmecfs.org/sh...r-reviewers-want-quot-additional-studies-quot
... Retrovirologist William Switzer and his colleagues at the CDC conducted a blinded study ...
Switzer's paper was delayed to give the CDC a chance to review his paper and methods in more detail, and to give Switzer's team a chance to perform more tests, says Stephen Monroe, director of the CDC's Division of High-Consequence Pathogens and Pathology. The delay lasted three weeks, and resulted in no changes to the manuscript, Switzer says.
And regarding the NIH/FDA paper:
... CDC officials learned of a contradictory study by the NIH and FDA team, reported at a meeting by NIH researcher Harvey Alter. Although a PNAS spokeswoman reportedly told The Wall Street Journal that the study had been accepted for publication, press officers at PNAS refused to comment on the matter today. One scientist familiar with the issue said that the journal's editor-in-chief, cell biologist Randy Schekman of the University of California, Berkeley, sent the paper out for further review after government agencies requested the publication delay. That review came back with requests for additional studies, the scientist says.
http://www.nature.com/news/2010/100702/full/news.2010.332.html?s=news_rss
http://www.forums.aboutmecfs.org/sh...r-reviewers-want-quot-additional-studies-quot